abrdn Life Sciences Investors Overviewabrdn Life Sciences Investors Net Income
Profitability analysis for HQL.
Quarterly Net Income
$65.34M
↑ 238.33% YoY
As of Mar 2026
Annual Net Income (TTM)
$185.97M
↑ 156.07% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...